Aristolochic Acid and Hepatocellular Carcinoma: A Critical Review of Genotoxic and Inflammatory Mechanisms
International Journal of Molecular Sciences · 25.05.2026 · 27 (11) · 4746
DOI: 10.3390/ijms27114746 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.05.2026. Verfasst von Yupeng Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Biological Product Control, National Institutes for Food and Drug Control, Beijing 102629, China. Hauptthemen laut MEDLINE: Aristolochic Acids, Liver Neoplasms, Carcinoma, Hepatocellular, Inflammation. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Major Project of China.
Abstract (Originalsprache)
Aristolochic acid (AA), a naturally occurring compound found in Aristolochia plants, is a well-established nephrotoxin and Group 1 carcinogen. Emerging evidence suggests a potential link between AA exposure and hepatocellular carcinoma (HCC), one of the leading causes of cancer-related mortality worldwide. This review critically evaluates current knowledge on AA’s hepatic metabolism, its formation of persistent DNA adducts, and the induction of inflammatory responses in the liver. Based on preclinical and indirect human evidence, we propose a working hypothesis that AA may contribute to hepatocarcinogenesis through a dual mechanism: genotoxic (primarily via H-ras and p53 mutations resulting from AA-DNA adducts) and non-genotoxic (via chronic inflammation involving IL-6, TNF-α, and NF-κB activation, as well as epithelial–mesenchymal transition). We note, however, that these mechanisms remain to be validated in human cohorts and do not yet establish causality. Recent studies have identified novel mechanisms, including PDK4-mediated mitochondrial dysfunction, ferroptosis inhibition via p53 hijacking, and ARID1A deficiency as a susceptibility factor. A recent meta-analysis quantified a significantly increased risk of liver cancer following AA exposure in epidemiological studies. While direct causal evidence in humans remains limited, the high mutational burden observed in AA-exposed liver tissues warrants caution. Nevertheless, the primary public health priority pertains to the prevention of AA exposure. Further epidemiological and mechanistic studies are urgently needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Biological Product Control, National Institutes for Food and Drug Control, Beijing 102629, China.
- National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 100176, China.
ORCID-Profile: Yikun Zhang, Xingchao Geng
Förderung
- National Science and Technology Major Project of China
Zitieren
APA
Wang, Y., Zhang, Y., Ren, T., Yuan, L., & Geng, X. (2026). Aristolochic Acid and Hepatocellular Carcinoma: A Critical Review of Genotoxic and Inflammatory Mechanisms. International Journal of Molecular Sciences, 27(11), 4746. https://doi.org/10.3390/ijms27114746
Vancouver
Wang Y, Zhang Y, Ren T, Yuan L, Geng X. Aristolochic Acid and Hepatocellular Carcinoma: A Critical Review of Genotoxic and Inflammatory Mechanisms. International Journal of Molecular Sciences. 2026;27(11):4746. doi:10.3390/ijms27114746
BibTeX
@article{Wang2026,
author = {Wang, Yupeng and Zhang, Yikun and Ren, Tianqi and Yuan, Liyong and Geng, Xingchao},
title = {Aristolochic Acid and Hepatocellular Carcinoma: A Critical Review of Genotoxic and Inflammatory Mechanisms},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {11},
pages = {4746},
doi = {10.3390/ijms27114746}
}
EUVIMED